National Institute of Dental & Craniofacial Research; Notice of Meeting, 53236 [05-17680]
Download as PDF
<![CDATA[
53236
Federal Register / Vol. 70, No. 172 / Wednesday, September 7, 2005 / Notices
Time: 1:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD
20892. (Telephone Conference Call).
Contact Person: Valerie L. Prenger,
PhD, Health Scientist Administrator,
Review Branch, Room 7214, Division of
Extramural Affairs, National Heart,
Lung, and Blood Institute, 6701
Rockledge Drive, MSC 7924, Bethesda,
MD 20892–7924, (301) 435–0270,
prengerv@nhlbi.nih.gov.
This notice is being published less
than 15 days prior to the meeting due
to the timing limitations imposed by the
review and funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: August 29, 2005.
Anthony M. Coelho, Jr.,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–17681 Filed 9–6–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Dental and
Craniofacial Research Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
VerDate Aug<18>2005
15:05 Sep 06, 2005
Jkt 205001
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Dental and Craniofacial Research Council.
Date: September 23, 2005.
Open: 8:30 a.m. to 11:55 a.m.
Agenda: Director’s Report, Implementation
Plan Report, Concept Clearances.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference Rm.
6C10, Bethesda, MD 20892.
Closed: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference Rm.
6C10, Bethesda, MD 20892.
Contact Person: Norman S Braveman, PhD,
Assistant to the Director, NIH–NIDCR,
Building 31, Rm. 5B55, Bethesda, MD 20892,
(301) 594–2089, Norman.Braveman@nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s hope page: https://
www.nidcr.hih.gov/about, where an
agenda and any additional information
for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: August 29, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–17680 Filed 9–6–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
Waiver of Compliance With Navigation
and Inspection Laws
Office of the Secretary, DHS.
Notice.
AGENCY:
ACTION:
Hurricane Katrina is one of the largest
natural disasters to ever strike the
United States. It has significantly
disrupted production of oil and gas in
the Gulf of Mexico, has caused many
Gulf Coast oil refineries to go out of
service because of flooding, lack of
electric power or other reasons, and has
significantly disrupted the pipeline
transportation of oil and refined
products from the Gulf Coast States.
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
These production losses, outages and
disruptions have already caused large
runups in the price of oil, gasoline and
other refined products. The Department
of Homeland Security is also now
receiving reports of threatened or actual
shortages of gasoline, jet fuel, and other
refined products, and of the rationing of
these fuels, both in the Southeast U.S.
and in other locations throughout the
country.
Numerous companies that produce
and/or ship petroleum and/or refined
petroleum products have submitted to
the Department requests for waivers of
the Merchant Marine Act of 1920 (the
‘‘Jones Act’’ ). 46 U.S.C. App. section 1.
This and related laws are generally
referred to as the ‘‘coastwise laws.’’
These laws provide, among other things,
that only vessels built and owned by
citizens of the United States and flagged
in the United States can carry
merchandise between U.S. ports.
The Secretary of Homeland Security
is vested with the authority and
discretion to waive the coastwise laws
‘‘to such extent and in such manner and
upon such terms as he may prescribe,
either upon his own initiative or upon
the written recommendation of the head
of any other Government agency,
whenever he deems that such action is
necessary in the interest of national
defense.’’ In consultation with and upon
the recommendation of the Secretary of
Energy, I have determined that such a
waiver, in accordance with the terms set
forth below, is in the interest of the
national defense.
The catastrophic destruction brought
about by Hurricane Katrina has
dramatically impeded, and in some
places in the affected region stopped
altogether, production and
transportation or transmission of oil,
refined petroleum products, natural gas,
and electricity. Much of the lost oil
production is from producing areas in
the Gulf of Mexico which have been
leased pursuant to programs of the
Department of the Interior. This lost
production, refining and transportation
capacity has resulted in the threatened
rationing and unavailability of gasoline,
jet fuel and other refined products, and
threatens the Nation’s economic and
national security. I believe that waiver
of the coastwise laws would facilitate
the transportation of oil and refined
petroleum products in and from
portions of the United States devastated
by the Hurricane, and to other regions
affected by the disruptions that have
occurred in the Gulf Coast area.
Therefore, I am exercising my
discretion and authority to waive the
coastwise laws generally for the
transportation of petroleum and refined
E:\FR\FM\07SEN1.SGM
07SEN1
]]>Agencies
[Federal Register Volume 70, Number 172 (Wednesday, September 7, 2005)]
[Notices]
[Page 53236]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-17680]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Advisory Dental and Craniofacial Research Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Dental and Craniofacial
Research Council.
Date: September 23, 2005.
Open: 8:30 a.m. to 11:55 a.m.
Agenda: Director's Report, Implementation Plan Report, Concept
Clearances.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Rm. 6C10, Bethesda, MD 20892.
Closed: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Rm. 6C10, Bethesda, MD 20892.
Contact Person: Norman S Braveman, PhD, Assistant to the
Director, NIH-NIDCR, Building 31, Rm. 5B55, Bethesda, MD 20892,
(301) 594-2089, Norman.Braveman@nih.gov.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Information is also available on the Institute's/Center's hope
page: https://www.nidcr.hih.gov/about, where an agenda and any
additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: August 29, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-17680 Filed 9-6-05; 8:45 am]
BILLING CODE 4140-01-M
